Mail

UK markets close in 1 hour 42 minutes

FTSE 100
8,124.96
+46.10(+0.57%)
FTSE 250
19,783.36
+181.38(+0.93%)
AIM
755.01
+1.89(+0.25%)
GBP/EUR
1.1675
+0.0019(+0.16%)
GBP/USD
1.2504
-0.0007(-0.06%)
Bitcoin GBP
51,337.47
+619.84(+1.22%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Zentalis Pharmaceuticals, Inc. (ZNTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

10.98

-0.01

(-0.09%)

As of 09:47AM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	779.50M
Enterprise value	339.73M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	1.78
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-1.35

Trading information

Stock price history

Beta (5Y monthly)	1.73
52-week change ³	-50.14%
S&P500 52-week change ³	21.08%
52-week high ³	31.46
52-week low ³	9.56
50-day moving average ³	14.04
200-day moving average ³	17.26

Share statistics

Avg vol (3-month) ³	835.25k
Avg vol (10-day) ³	735.59k
Shares outstanding ⁵	70.96M
Implied shares outstanding ⁶	70.96M
Float ⁸	50.35M
% held by insiders ¹	4.27%
% held by institutions ¹	115.06%
Shares short (15 Apr 2024) ⁴	16.64M
Short ratio (15 Apr 2024) ⁴	22.49
Short % of float (15 Apr 2024) ⁴	31.89%
Short % of shares outstanding (15 Apr 2024) ⁴	23.45%
Shares short (prior month 15 Mar 2024) ⁴	16.74M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-28.53%
Return on equity (ttm)	-67.09%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-247.6M
Net income avi to common (ttm)	-292.19M
Diluted EPS (ttm)	-4.47
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	482.92M
Total cash per share (mrq)	6.8
Total debt (mrq)	45.77M
Total debt/equity (mrq)	10.46%
Current ratio (mrq)	7.16
Book value per share (mrq)	6.18

Cash flow statement

Operating cash flow (ttm)	-207.82M
Levered free cash flow (ttm)	-86.97M